In April of 1996, Perkin-Elmer acquired Topix. Tropix, Inc. is involved in the development, manufacture and sale of chemiluminescent technology for the life sciences. The Company1s products are designed to provide the highest sensitivity available for clinical diagnostic and molecular biology research and pharmceutical screening laboratories for the detection and microanalysis of biomolecules.
